Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Cancer Letters|May 2, 2012
Estrogen receptor positive breast cancer identified by 95-gene classifier as at high risk for relapse shows better response to neoadjuvant chemotherapyRyo Tsunashima, Yasuto Naoi, Kazuki Kishi, et al.
Cancer Science|February 11, 2012
GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancerTomohiro Miyake, Takahiro Nakayama, Yasuto Naoi, et al.
Translational Oncology|February 28, 2020
Molecular Barcode Sequencing of the Whole Ligand Binding Domain of the ESR1 Gene in Cell-Free DNA from Patients with Metastatic Breast CancerNanae Masunaga, Naofumi Kagara, Daisuke Motooka, et al.
Clinical Breast Cancer|January 28, 2014
72-gene classifier for predicting prognosis of estrogen receptor-positive and node-negative breast cancer patients using formalin-fixed, paraffin-embedded tumor tissuesMinako Nishio, Yasuto Naoi, Ryo Tsunashima, et al.
Cancer Letters|April 26, 2011
Gene expression signature of TP53 but not its mutation status predicts response to sequential paclitaxel and 5-FU/epirubicin/cyclophosphamide in human breast cancerKazuteru Oshima, Yasuto Naoi, Kazuki Kishi, et al.
Cancer Letters|July 13, 2014
Development of a prediction model for lymph node metastasis in luminal A subtype breast cancer: the possibility to omit sentinel lymph node biopsyChiaki Nakauchi, Yasuto Naoi, Kenzo Shimazu, et al.
Breast Cancer Research and Treatment|September 15, 2017
Highly sensitive detection of ESR1 mutations in cell-free DNA from patients with metastatic breast cancer using molecular barcode sequencingNanae Masunaga, Naofumi Kagara, Daisuke Motooka, et al.
Breast (Edinburgh, Scotland)|August 25, 2007
Quantitative assessment of mammographic density and breast cancer risk for Japanese womenYasuyuki Kotsuma, Yasuhiro Tamaki, Toshihiro Nishimura, et al.
Translational Oncology|May 31, 2020
Detection of ctDNA with Personalized Molecular Barcode NGS and Its Clinical Significance in Patients with Early Breast CancerTetsuhiro Yoshinami, Naofumi Kagara, Daisuke Motooka, et al.
Frontiers in Oncology|March 25, 2026
Analysis of <i>PIK3CA</i> mutations in the lysate of sentinel lymph nodes in patients with early breast cancerSung Ae Park, Nanae Masunaga, Takanori Kin, et al.
Pageof 13